MMPI-1154 is a promising novel cardio-cytoprotective imidazole-carboxylic acid (ICA) MMP-2 inhibitor( IC 50 =6.6 μM) and can be used for the study of acute myocardial infarction. MMPI-1154 also inhibits the activity of MMP-13 , MMP-1 and MMP-9 with IC 50 s of 1.8 μM,10 μM, and 13 μM, respectivelyIn VitroMMPI-1154 (1-100 μM) inhibits MMP-2 enzyme isolated from rat heart in vitro, and 100% inhibition appears at the concentraction 100 μM. MMPI-1154 (1 μM) shows significant cardio-cytoprotecion, significantly decreases infarct size in an ex vivo model for acute myocardial infarction. MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:SolidIC50& Target:MMP-2 6.6 μM (IC 50 ) MMP-13 1.8 μM (IC 50 ) MMP-1 10 μM (IC 50 ) MMP-9 13 μM (IC 50 ). Specification: 0.99 Molecular Formula: C26H24FN3O3 Molecular Weight: 445.49 PubChem CID: 68027884 Isomeric SMILES: C1=CC=C(C=C1)COC2=CC=C(C=C2)CN(CC3=CC=C(C=C3)F)CC4=NC=C(N4)C(=O)O
- UPC:
- 51322601
- Condition:
- New
- Availability:
- 8-12 weeks
- Weight:
- 1.06 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- M649292-5mg
- CAS:
- 1382722-47-5
- Product Size:
- 5mg
